Back

Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant

2021-02-05 infectious diseases Title + abstract only
View on medRxiv
Show abstract

Antibody responses against the SARS-CoV-2 Spike protein correlate with protection against COVID-19. Serum neutralizing antibodies appear early after symptom onset following SARS-CoV-2 infection and can last for several months. Similarly, the messenger RNA vaccine, mRNA-1273, generates serum neutralizing antibodies that are detected through at least day 119. However, the recent emergence of the B.1.1.7 variant has raised significant concerns about the breadth of these neutralizing antibody respon...

Predicted journal destinations

1
Nature Communications
483 training papers
Top 4% 16.3%
2
The Journal of Infectious Diseases
137 training papers
Top 0.9% 5.9%
3
mBio
34 training papers
#1 5.9%
4
Clinical Infectious Diseases
219 training papers
Top 7% 5.5%
5
Nature Medicine
88 training papers
Top 0.7% 3.8%
6
Scientific Reports
701 training papers
Top 70% 3.5%
7
Cell
28 training papers
Top 0.2% 3.5%
8
Cell Reports Medicine
49 training papers
Top 0.8% 3.5%
9
New England Journal of Medicine
49 training papers
Top 0.7% 3.5%
10
Nature
58 training papers
Top 0.4% 3.5%
11
PLOS ONE
1737 training papers
Top 91% 2.6%
12
Science
46 training papers
Top 1% 2.0%
13
JCI Insight
63 training papers
Top 4% 1.8%
14
The Lancet Infectious Diseases
57 training papers
Top 2% 1.8%
15
Emerging Infectious Diseases
84 training papers
Top 7% 1.8%
16
Viruses
79 training papers
Top 3% 1.8%
17
Science Translational Medicine
40 training papers
Top 1% 1.8%
18
BMC Medicine
155 training papers
Top 19% 1.4%
19
Open Forum Infectious Diseases
124 training papers
Top 10% 1.4%
20
Frontiers in Immunology
140 training papers
Top 8% 1.4%
21
Vaccine
140 training papers
Top 6% 1.4%
22
eLife
262 training papers
Top 38% 1.2%
23
Journal of Medical Virology
95 training papers
Top 9% 1.2%
24
Nature Microbiology
21 training papers
Top 0.3% 1.1%
25
PLOS Pathogens
35 training papers
Top 2% 1.1%
26
International Journal of Infectious Diseases
115 training papers
Top 19% 1.1%
27
Vaccines
131 training papers
Top 10% 1.1%
28
iScience
74 training papers
Top 11% 0.9%
29
eBioMedicine
82 training papers
Top 9% 0.9%
30
Journal of Infection
64 training papers
Top 9% 0.9%